Control group:Patent foramen ovale occluder (Beijing Huayi Shengjie Technology Co., Ltd., 20173134477)

2 trials

Sponsors

Shenzhen Hospital, Fuwai Hospital, Chinese Academy of Medical Sciences

Conditions

Patent foramen ovale (PFO) related stroke or transient ischemic attack (TIA)

Unknown Phase

Multicenter, randomized controlled, non-inferiority study to evaluate the safety and effectiveness of transcatheter patent foramen ovale suture system

Active, not recruitingChiCTR2400085085

Shenzhen Hospital, Fuwai Hospital, Chinese Academy of Medical SciencesPatent foramen ovale (PFO) related stroke or transient ischemic attack (TIA)

Start: 2024-06-01Updated: 2024-06-03

Prospective, multicenter, randomized controlled, non-inferior evaluation of the safety and efficacy of biodegradable occluder systems in clinical trials

Active, not recruitingChiCTR2400086972

Shenzhen Hospital, Fuwai Hospital, Chinese Academy of Medical SciencesPatent foramen ovale (PFO) related stroke or transient ischemic attack (TIA)

Start: 2024-01-08Updated: 2024-07-22